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Summary
 
To elucidate the role of A1, a new member of the Bcl-2 family of apoptosis regulators active in
hematopoietic cell apoptosis, we established mice lacking A1-a, a subtype of the A1 gene in
mice (A1-a
 
2
 
/
 
2
 
 mice). Spontaneous apoptosis of peripheral blood neutrophils of A1-a
 
2
 
/
 
2
 
 mice
was enhanced compared with that of either wild-type mice or heterozygous mutants (A1-a
 
1
 
/
 
2
 
mice). Neutrophil apoptosis inhibition induced by lipopolysaccharide treatment in vitro or
transendothelial migration in vivo observed in wild-type mice was abolished in both A1-a
 
2
 
/
 
2
 
and A1-a
 
1
 
/
 
2
 
 animals. On the other hand, the extent of tumor necrosis factor 
 
a
 
–induced accel-
eration of neutrophil apoptosis did not differ among A1-a
 
2
 
/
 
2
 
, A1-a
 
1
 
/
 
2
 
, and wild-type mice.
The descending order of A1 mRNA expression was wild-type, A1-a
 
1
 
/
 
2
 
, and A1-a
 
2
 
/
 
2
 
. Taken
together, these results suggest that A1 is involved in inhibition of certain types of neutrophil
apoptosis.
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C
 
ontrol of neutrophil function seems important for re-
taining an effective level of bacterial killing and other
physiological properties while avoiding damage to normal
tissues. The short life of neutrophils may ensure fulfillment
of the latter requirement, since an early death after accom-
plishing their physiological task may prevent possible dam-
age to normal tissues, which might occur with a prolonged
survival of these cells. However, there are situations that
require neutrophils to function actively for an extended pe-
riod, such as during bacterial infection. In fact, these cells
have been found to survive for longer periods in various
situations. We have demonstrated previously that apoptosis
of peritoneal exudate neutrophils (PEN)
 
1
 
 and peripheral
blood neutrophils (PBN) obtained from rats intraperito-
neally injected with inflammatory agents is severely inhib-
ited (1). On the other hand, certain agents accelerate apop-
tosis of these cells. TNF-
 
a
 
 enhances apoptosis of human (2)
and rat (1) neutrophils, and PMA induces prompt neutro-
phil death, although in a different manner from that of typ-
 
ical apoptosis or necrosis (3). However, the mechanisms re-
sponsible for the regulation of neutrophil apoptosis remain
largely unknown.
Several genes have been implicated in the regulation of
cell death, including those of the 
 
bcl-2
 
 family (4–9), Fas/
Apo1 (10, 11), 
 
c-myc
 
 (12), p53 (13), and 
 
nur77
 
 (14). Bcl-2,
the 
 
bcl-2
 
 product, blocks or delays cell death after adminis-
tration of death-inducing agents or growth factor with-
drawal (4). Analysis of 
 
bcl-2
 
–deficient mice provided evi-
dence that 
 
bcl-2
 
 is required for ensuring the full life span of
mature lymphocytes in vivo (15–17). A newly recognized
member of the 
 
bcl-2
 
 family, A1, was originally isolated
from a cDNA library prepared from GM-CSF–treated
mouse bone marrow cultures. Murine A1 is expressed in
the thymus, spleen, and bone marrow, and specifically in
the hematopoietic cell lineages including Th cells, mac-
rophages, and neutrophils (9). Recently, a role for A1 in
protection against apoptosis was reported (18–20). It has
also been demonstrated that A1 is the only known Bcl-2
family member to be induced by the inflammatory cyto-
kines TNF-
 
a
 
 and IL-1
 
b
 
 (21).
It has been shown that Bcl-2 and Bcl-x
 
L
 
 can inhibit most
apoptosis. Both of these proteins are absent in mature neu-
trophils although Bcl-2 is expressed in early myeloid cells
 
1
 
Abbreviations used in this paper:
 
 ES, embryonic stem cells; PBN, peripheral
blood neutrophils; PEN, peritoneal exudate neutrophils.
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of the bone marrow (22). Expression of a newly recognized
member of the Bcl-2 family, A1, alone of all the known
proteins that inhibit neutrophil apoptosis, suggests that A1
plays a major role in the prevention of this apoptosis. We
have reported previously that in the murine genome A1
consists of at least four genes, A1-a, -b, -c, and -d (23), all
of which have a high degree of homology with each other
at the nucleotide and amino acid sequence levels. In this
study, we used gene targeting to establish mice lacking
A1-a, one of the A1 subtypes (A1-a
 
2
 
/
 
2
 
 mice), in order
to investigate the possible role of A1-a in the regulation
of neutrophil apoptosis. We describe here acceleration of
neutrophil apoptosis in A1-a
 
2
 
/
 
2
 
 mice and discuss its possi-
ble mechanisms.
 
Materials and Methods
 
Establishment of the A1-a
 
2
 
/
 
2
 
 Mouse.
 
Genomic DNA corre-
sponding to the A1-a locus was isolated from a library of 129Sv
mouse DNA (Stratagene Inc., La Jolla, CA). The XbaI-HindIII
fragment (4 kb), containing exon 1 of the A1-a coding region (1–
140 amino acids), was deleted and replaced with a PGK-neo-
polyadenylate [poly(A)] cassette. The targeting vector, pA1-a-
KO-neo, contains a 1.1 kb of homology 5
 
9
 
, 6.0 kb 3
 
9
 
 of the
drug-resistant gene, and a PGK-tk-poly(A) cassette. The linear-
ized pA1-a-KO-neo was transfected into E14 embryonic stem
(ES) cells. For screening of A1-a-KO targeted clones by PCR, an
A1-a flanking primer (5
 
9
 
-CATCATAGTTTGTCATTCAGG-
AAG-3
 
9
 
) and a PGK-poly(A)-specific primer (5
 
9
 
-GGGTGGGG-
TGGGATTAGATAAATG-3
 
9
 
) were used. PCR-positive clones
were analyzed by Southern blot hybridization to confirm that
there had been homologous recombination. Mutated ES cells
were microinjected into C57BL/6 blastocysts that were then im-
planted into uteri of pseudopregnant ICR mice to generate chi-
meric offspring. Male chimeric mice were mated with C57BL/6
females, and A1-a
 
1
 
/
 
2
 
 mice were intercrossed to obtain A1-a
 
2
 
/
 
2
 
mice. Maintenance, transfection, and selection were carried out as
described previously (24).
 
Animals.
 
A1-a
 
2
 
/
 
2
 
 mice and A1-a
 
1
 
/
 
2
 
 mice were maintained
in the animal center of our medical school in an environment kept
free of pathogenic bacteria. The genotypes of newborn mice were
examined by PCR at 4–8 wk of age. PCR was performed using
genomic DNA obtained from a tail biopsy specimen. Two oligo-
nucleotide primers, 5
 
9
 
-ATGGCTGAGTCTGAGCTCATG-3
 
9
 
and 5
 
9
 
-CCAACCTCCATTCCGCCGTATC-3
 
9
 
, were used for
endogenous detection, and two other primers, 5
 
9
 
-CATCATAG-
TTTGTCATTCAGGAAG-3
 
9
 
 and 5
 
9
 
-GGGTGGGGTGGGAT-
TAGATAAATG-3
 
9
 
, were used for detecting knockouts. C57BL/6
and 129Sv mice were used as controls. The mice used for experi-
ments had body weights of 25–35 g.
 
Preparation of PBN.
 
We separated PBN from blood using a
partially modified method of Tsuchida et al. (1). Heparinized pe-
ripheral blood was obtained by cardiac puncture. Blood from
three to seven mice of the same group was usually pooled to-
gether to obtain a sufficient number of PBN for the apoptosis as-
say. RBCs were sedimented by the addition of an equal volume
of 3% (wt/vol) dextran T-500 (25) (Pharmacia Biotech AB, Upp-
sala, Sweden) in PBS. The mixture of blood and dextran was al-
lowed to stand in a 15-ml conical tube (Falcon FAL2096; Becton
Dickinson Labware, Lincoln Park, NJ) at room temperature for
12–15 min to permit the erythrocytes to sediment. The leuko-
 
cyte-rich supernatant (buffy coat) was transferred to another con-
ical tube which was then filled with Eagle’s MEM (Nissui Phar-
maceutical Co., Ltd., Tokyo, Japan) and centrifuged at 650 
 
g
 
 for
5 min at 4
 
8
 
C. The leukocyte-rich erythrocyte layer at the bottom
was suspended in 5 ml of MEM and centrifuged on 5 ml of
Ficoll-Paque (specific gravity, 1.077; Pharmacia Biotech AB) at
800
 
 g
 
 for 10 min at 4
 
8
 
C. The erythrocytes in the pellet were lysed
by hypotonic shock. Neutrophils were washed with MEM, resus-
pended in RPMI 1640 medium (GIBCO BRL, Gaithersburg,
MD) supplemented with 10% FCS (Whittaker M.A. Bioprod-
ucts, Inc., Walkersville, MD), and used for experiments. The pu-
rity obtained was 
 
z
 
85–95%.
 
Preparation of PEN.
 
Mice were injected intraperitoneally
with 4–5 ml of 3% proteose peptone (Difco Laboratories Inc.,
Detroit, MI). 12 h later each mouse received the same injection
again. 3 h after the second injection mice were killed and PEN
were harvested twice by peritoneal lavage with 4 ml of cold hep-
arinized MEM. The cell suspension was washed by centrifugation
at 650 
 
g
 
 for 5 min at 4
 
8
 
C and the pellet was resuspended in 5 ml
MEM and centrifuged on 5 ml of Ficoll-Paque at 800 
 
g
 
 for 10 min
at 4
 
8
 
C. The neutrophils were washed with MEM and resuspended
in RPMI 1640 supplemented with 10% FCS and then used for
experiments. The approximate purity obtained was 
 
.
 
95%.
 
Neutrophil Culture.
 
Aliquots (0.4 ml) of neutrophil suspen-
sions (0.5 
 
3
 
 10
 
6
 
/ml) were seeded into 8-well culture slides (Fal-
con FAL4118; Becton Dickinson Labware) and incubated at
37
 
8
 
C for varying periods of time in a 5% CO
 
2
 
 atmosphere. Neu-
trophils were cultured in the presence or absence of recombinant
human TNF-
 
a
 
 (gift from Dainippon Pharmaceutical Co., Ltd.,
Tokyo, Japan) or LPS (Difco Laboratories Inc.). The concentra-
tion of endotoxin in the FCS used was 
 
,
 
100 pg/ml.
 
Examination of Neutrophil Apoptosis.
 
Neutrophils incubated un-
der specific conditions were stained with May-Giemsa and apop-
totic cells were counted under light microscopy (
 
3
 
1,000).
Representative microscopic images of normal and apoptotic neu-
trophils are shown in Fig. 1. Approximately 300–1200 cells were
scanned per specimen.
Figure 1. Representative microscopic images of normal and apoptotic
neutrophils. Aliquots (0.4 ml) of PBN suspensions of A1-a2/2 mice (0.5 3
106/ml) were incubated at 378C for 12 h in RPMI 1640 medium. Arrows
indicate normal neutrophils and arrowhead indicates an apoptotic neutro-
phil containing condensed and fragmented nuclei (original magnification,
31,000, May-Giemsa stain). 
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Detection of A1 mRNA by RT-PCR and Its Quantification by
Competitive RT-PCR.
 
To detect A1 mRNA, the total RNA
(1 
 
m
 
g) isolated from neutrophils was reverse transcribed with
AMV reverse transcriptase (TaKaRa, Ohtsu, Japan) using an oligo
dT primer. First-strand cDNA synthesis products were amplified
in reaction volumes of 50 
 
m
 
l using the primers 5
 
9
 
-AATTCCAA-
CAGCCTCCAGATATG-3
 
9
 
 and 5
 
9
 
-GAAACAAAATATCTG-
CAACTCTGG-39, together with 0.625 U Ex-Taq polymerase
(TaKaRa) in a DNA Thermal Cycler (Perkin-Elmer Corp., Nor-
walk, CT). PCR products were digested with 10 U of the restric-
tion enzymes, BglII and NsiI (Boehringer Mannheim Biochemi-
cals, Indianapolis, IN), to distinguish each subtype, and then
electrophoresed on 2% agarose gels. The agarose gel image was
captured by densitometer and relative quantification of each band
was determined by NIH image analysis. To quantify A1 mRNA,
a competitive RT-PCR was performed. The DNA competitor
was amplified from lDNA with primers 59-ATTTAGGTGA-
CACTATAGAATACAATTCCAACAGCCTCCAGATATG-39
and 59-GAAACAAAATATCTGCAACTCTGGAGAGTTTC-
TGCGGCAGTTAA-39 using a competitive DNA construction
kit (TaKaRa). 1–109 copies of the DNA competitors were pre-
pared by a 10-fold dilution and amplified in a DNA Thermal Cy-
cler with 1 ml of first-strand cDNA in reaction volumes of 50 ml
using primers 59-AATTCCAACAGCCTCCAGATATG-39 and
59-GAAACAAAATATCTGCAACTCTGG-39 together with
0.625 U Ex-Taq polymerase. PCR products were electropho-
resed on 2% agarose gels, and the strengths of target bands were
compared visually with the competitor bands for each lane.
Data Analysis. Results were expressed as means of at least five
independent experiments. Statistical significance was determined
by the unpaired t test.
Results
A1-a Gene Targeting. The murine A1 genomic locus is
comprised of two exons spanning z4.5 kb. The targeting
construct was designed to delete the protein coding region
of exon 1 (Fig. 2 A). Electroporation of the linearized tar-
geting vector and G418/gancyclovir selection for homolo-
gous recombinants were carried out as described in Materi-
als and Methods. G418/gancyclovir double-resistant ES
cell clones (67 clones) were screened for homologous re-
combination events by PCR, and two clones (3.0%) were
found to have recombined homologously. All of these
clones were confirmed by Southern blot analysis to contain
the desired targeted allele (Fig. 2 B). The two clones were
injected into C57BL/6 blastocysts, and high coat-color
chimeric males that transmitted the mutant allele to the
germline were obtained. Heterozygous offspring of chime-
ras appeared entirely normal and were fertile. To determine
the relative expression level of mRNA of each A1 subtype,
RNA obtained from neutrophils was amplified. The RT-
PCR products were then digested with the restriction
enzymes BglII and NsiI to distinguish each subtype. Expres-
sion ratios of each subtype were as follows: among the
A1-a2/2 mice, the A1-b/A1-d ratio was 3:2; and in A1-a1/2
mice, the A1-a/A1-b/A1-d ratio was 4:7:6 (data not
shown). Ratios for wild-type mice were as follows: among
C57BL/6 mice, the A1-a/A1-b/A1-d ratio was 3:4:3; and
in 129Sv mice, this ratio was 7:8:5 (23).
Phenotype of A1-a2/2 Mice. Heterozygote matings yielded
wild-type (1/1), heterozygous (1/2), and nullizygous
(2/2) offspring at roughly the expected Mendelian ratio,
thus indicating no significant embryonic lethality. At birth,
these homozygotes were indistinguishable from their wild-
type and heterozygous littermates. However, aging caused
hair loss on the head and face of both A1-a2/2 and A1-a1/2
mice by 8–12 wk of age (Fig. 3).
Despite the hair loss, the outward appearance of A1-a2/2
and A1-a1/2 mice was normal (Fig. 3). There was no evi-
dence of illness in either of these groups in mice up to 12
mo of age.
Accelerated Spontaneous Apoptosis of PBN in A1-a2/2
Mice. Several groups have reported that transfection of A1
into cell lines prolongs cell survival (18–20). However, there
has been no report evaluating the relationship between en-
Figure 2. Targeted disruption of the mouse A1-a gene. (A) Structure of the targeting vector, pA1-a-KO-neo, restriction map of the mouse A1-a gene,
and structure of the mutated locus after homologous recombination. The coding exons are depicted by hatched boxes. The genomic fragment used as a
probe for Southern blotting is shown as a hatched bar. neo was placed in a reverse orientation relative to the A1 transcription. The expected sizes of the
EcoRI fragments that hybridize with the probe are indicated. (B) Southern blot analysis of genomic DNA extracted from ES cells. The DNA was di-
gested with EcoRI and hybridized with the probe. The sizes of wild-type A1-a (WT (A1-a)), wild-types A1-b–d (WT A1-b, c, d), and disrupted (KO
(A1-a)) alleles are shown; the genotypes are presented above the lanes.1988 Accelerated Neutrophil Apoptosis in A1-a Knockout Mice
dogenous A1 and apoptosis. To determine whether A1-a
plays a role in neutrophil apoptosis, we studied the spontane-
ous apoptosis of PBN obtained from A1-a2/2 mice. We first
examined spontaneous apoptosis of PBN from control
C57BL/6 and 129Sv mice. Since there was no difference in
PBN apoptosis within these two strains (data not shown),
we used mice of these groups as wild-type controls. Spon-
taneous apoptosis of PBN obtained from wild-type and
A1-a1/2 mice gradually increased during incubation in
vitro, and there was no significant difference between these
two groups. On the other hand, spontaneous apoptosis of
PBN from A1-a2/2 mice was significantly greater than that
of wild-type or A1-a1/2 mice at 12 and 24 h of incubation
(Fig. 4).
Absence of Apoptosis Inhibition of PEN and LPS-treated
PBN in A1-a2/2 and A1-a1/2 Mice. We and others have
demonstrated that neutrophil apoptosis is modulated ac-
cording to the conditions under which the cell is placed (1,
26–30). To determine whether regulation of apoptosis in
similar situations can occur in A1-a2/2 mice, we examined
both the level of apoptosis of PEN, which was found to be
lower than that of PBN in normal rats (1), and the level of
apoptosis of PBN treated with LPS, which has been shown
to be significantly inhibited in human preparations (26, 27).
Table 1 shows that, in wild-type mice, apoptosis of neutro-
phils under the two sets of conditions mentioned above
(PEN and LPS treatment) was significantly lower than that
of untreated PBN, as already reported (1, 26, 27). On the
other hand, in A1-a2/2 and A1-a1/2 mice, apoptosis of
PEN and LPS-treated PBN was not inhibited compared
with that of untreated PBN. These results indirectly suggest
that A1-a may be at least partially involved in neutrophil
apoptosis suppression induced by LPS treatment in vitro
and transendothelial migration in vivo. Furthermore, when
apoptosis of PEN and LPS-treated PBN were compared in
A1-a2/2, A1-a1/2, and wild-type mice, the descending or-
der of apoptosis was A1-a2/2, A1-a1/2, and wild-type,
with significant differences observed among these groups at
12 h of incubation (Table 1).
Relative Expression of A1 mRNA in Neutrophils of A1-a2/2,
A1-a1/2, and Wild-type Mice. The above results show that
neutrophil apoptosis is upregulated in both A1-a2/2 and
A1-a1/2 mice. To begin to clarify the mechanisms in-
volved in this phenomenon, we examined the relative
expression of A1 mRNA in neutrophils obtained from
mice of different genotypes. By competitive RT-PCR, the
amount of A1 mRNA in neutrophils was most prominent
in wild-type mice, second in A1-a1/2 mice, and smallest in
A1-a2/2 mice (Table 2), suggesting that the level of neu-
trophil apoptosis in certain situations may be reflected by
the level of A1 mRNA expression in these cells.
No Reduction in the Number of PBN and PEN in A1-a2/2
Mice. The finding that spontaneous apoptosis of PBN and
PEN was enhanced in A1-a2/2 mice (Table 1) led us to
speculate that the number of PBN and PEN in A1-a2/2
mice might be smaller than in wild-type mice. To answer
this question, we determined the number of PBN in un-
treated A1-a2/2 , A1-a1/2 , wild-type C57BL/6, and
129Sv mice. Unexpectedly, the number of PBN in these
mice did not differ. Furthermore, using these four different
strains of mice, we examined the number of PBN and PEN
at 3, 6, 12, 24 h, as well as 3 h after a booster injection at 12 h
after intraperitoneal injection of proteose peptone. The
number of PBN and PEN in the four groups did not signif-
icantly differ from each other at any of the time points after
the injection of the reagent (data not shown).
Lack of Change in Sensitivity to TNF-a–enhanced Neutrophil
Apoptosis in A1-a2/2 Mice. We demonstrated previously
that TNF-a enhances apoptosis of human (2) and rat (1)
neutrophils. To further explore possible mechanisms for
the enhancement of spontaneous apoptosis of PBN in A1-
a2/2 mice, we examined the sensitivity of these PBN in
Figure 3. Physical appearance of A1-a2/2 mice. Loss of hair around the
face and head can be seen. Despite the loss of hair, the outward appear-
ance of A1-a2/2 mice was normal.
Figure 4. Spontaneous apoptosis of PBN. Aliquots (0.4 ml) of PBN
(0.5 3 106/ml) were incubated for a period of up to 24 h in the absence
of apoptosis-inducing agents. The numbers of apoptotic neutrophils were
determined by light microscopic observation, as described in Materials
and Methods. The results are expressed as means and SEs of five experi-
ments. The unpaired t test was used to identify significant differences
(*P , 0.01) between the genotypes.1989 Hamasaki et al.
terms of TNF-a enhancement of apoptosis. Treatment
with this cytokine enhanced PBN apoptosis in all wild-
type, A1-a1/2, and A1-a2/2 mice at a 12 h incubation (Fig.
5). The extent of apoptosis enhancement by TNF-a was
not significantly different among these three groups of mice
(data not shown). On the other hand, apoptosis of PEN
was not enhanced in any of the A1-a2/2, A1-a1/2, or wild-
type mice by TNF-a (Fig. 5), similar to our results ob-
tained previously with normal rats (1).
Discussion
After establishing A1-a2/2 mice in this study, we were
able to show that spontaneous apoptosis of PBN and PEN
is enhanced in these animals. Although the mechanisms
governing the short life span of neutrophils and their
prompt spontaneous apoptosis remain obscure, downregu-
lation of bcl-2 expression during the terminal phase of neu-
trophilic differentiation (31, 32) could largely account for
the above phenomenon. It is well known that Bcl-2 inhib-
its apoptosis of many types of cells (4, 33) and that neutro-
phil apoptosis is inhibited in bcl-2 transgenic mice (34).
However, other members of the Bcl-2 family are also
involved in inhibiting apoptosis of various cells in certain
situations. Bcl-xL, a member of the Bcl-2 family, pre-
vents immunosuppressant-induced mature B cell apoptosis,
whereas Bcl-2 is not involved in this phenomenon (35).
Furthermore, Mcl-1, another member of the Bcl-2 family,
delays apoptosis induced by c-Myc overexpression in Chi-
nese hamster ovary cells (36). In this sense, A1, a new
member of the Bcl-2 family, may be a main suppressor of
neutrophil apoptosis for the following reasons: (a) transfec-
tion of A1 into various types of cells inhibits apoptosis (18–
20); (b) A1 is stably induced during G-CSF–stimulated
neutrophilic differentiation of a myeloid precursor cell line,
but transiently induced in a macrophage-like cell line or in
bone marrow–derived macrophages (9); (c) mouse neutro-
phils express all subtypes of A1, A1-a, A1-b, and A1-d (23);
(d) although overexpression of Bcl-2 inhibits spontaneous
neutrophilic differentiation of a myeloid precursor cell line,
overexpression of A1 does not (18) (However, this does
not preclude the possibility that A1 is active in neutro-
phils.); and (e) furthermore, no enhancement of T cell
apoptosis was observed in A1-a2/2 mice (Hatakeyama, S.,
unpublished results), which suggests a possible role for A1
in the restrictive lineage of hematopoietic cells.
Our present finding that A1-a2/2 mice exhibit enhanced
neutrophil apoptosis further strengthens the assumption
that A1 is a major suppressor of this process. Furthermore,
the finding that knockout of the A1-a subtype results in en-
Table 1. Absence of Apoptosis Inhibition of PEN and LPS-treated PBN in Both A1-a2/2 and A1-a1/2 Mice
Genotype
Source of
neutrophils Treatment
% Apoptotic cells 6 SE
P value using the unpaired t test
(12-h incubation) Incubation time
6 h 12 h vs. A1-a1/2 vs. Wild-type
A1-a2/2 PBN NT* 7.1 6 0.8 20.6 6 1.9 ,0.001 ,0.001
A1-a2/2 PBN LPS‡ 4.9 6 0.7 19.0 6 1.1 ,0.001 ,0.001
A1-a2/2 PEN NT 7.8 6 1.2 18.6 6 1.3 ,0.001 ,0.001
A1-a1/2 PBN NT 3.3 6 0.5 8.3 6 1.2 0.22
A1-a1/2 PBN LPS 3.7 6 0.5 9.2 6 1.0 ,0.05
A1-a1/2 PEN NT 5.1 6 1.8 11.0 6 2.2 ,0.05
Wild-type PBN NT 5.0 6 0.4 10.4 6 0.8
Wild-type PBN LPS 2.4 6 1.0§ 5.2 6 1.4§
Wild-type PEN NT 1.4 6 0.2§ 3.8 6 0.4§
Neutrophils from the indicated source were incubated for 6 or 12 h. Experiments were conducted five times.
*NT, not treated.
‡Neutrophils were incubated in the presence of LPS (10 mg/ml).
§P , 0.01 compared with PBN NT* by the unpaired t test.
Table 2. Relative Expression of A1 mRNA in Neutrophils 
Obtained from Mice with Different Genotypes
Genotype Relative expression*
A1-a2/2 1
A1-a1/2 10
C57BL/6 30‡
129Sv 100
*Relative expression was determined by competitive RT-PCR.
‡C57BL/6 A1 mRNA was weakly amplified compared with that of
129Sv. It is possible that primers designed from the sequence of 129Sv
mice did not anneal properly to C57BL/6 mRNA.1990 Accelerated Neutrophil Apoptosis in A1-a Knockout Mice
hancement of neutrophil apoptosis suggests that this sub-
type functions as an important suppressor of apoptosis of
these cells. However, inasmuch as cycloheximide treatment
of neutrophils of wild-type mice induces greater apoptosis
than that of A1-a2/2 (Hamasaki, A., unpublished results),
the other subtypes, A1-b and A1-d, may also be involved
in neutrophil apoptosis inhibition.
It has been shown previously that treatment of neutro-
phils in vitro with cytokines such as IL-1 (26), G-CSF (26),
GM-CSF (26, 28, 29), and IFN-g (26), which are detect-
able in inflammatory foci, inhibits apoptosis of these cells.
Furthermore, endothelial transmigration in vitro (30) and
in vivo (1) both delay neutrophil apoptosis. The present
finding that neutrophil apoptosis inhibition by LPS in vitro
and transendothelial migration in vivo were completely ab-
rogated in A1-a2/2 mice strongly suggests that A1-a is in-
volved in this inflammation-mediated suppression of apop-
tosis.
The present finding that spontaneous neutrophil apop-
tosis is accelerated in A1-a2/2 mice (Fig. 4) suggests that
A1-a is also involved in this suppression of apoptosis. The
constitutive expression of A1 mRNA in neutrophils of un-
treated wild-type mice supports this assumption. As the
mechanisms involved in spontaneous neutrophil apoptosis,
autocrine death induced by Fas/FasL interaction on the
neutrophil surface (37), reactive oxygen intermediates (38,
39), and caspase (40), have been suggested as playing an ac-
tive role in effector mechanisms, which may not necessarily
be mutually exclusive, and which may actually be interac-
tive to some degree. An examination of candidate mecha-
nisms and the manner in which A1 modulates apoptosis
will be the focus of future studies on A1 involvement in
spontaneous neutrophil apoptosis inhibition.
The finding in this study that inhibition of PEN and
LPS-treated PBN apoptosis was abrogated in both A1-a2/2
and A1-a1/2 mice, whereas acceleration of spontaneous
PBN apoptosis was observed in A1-a2/2 alone (Table 1),
may be explained as follows: in untreated PBN, the con-
centration of A1 protein in A11/2 may be sufficient to in-
hibit apoptosis, since mRNA expression of A1 in these
mice is 10-fold higher than in A1-a2/2, but only one tenth
that of wild-type 129Sv mice (Table 2). However, a greater
concentration of A1 protein may be required to inhibit
apoptosis of LPS-treated PBN or extravasated PEN, which
may explain the lack of inhibition in A1-a2/2 and A1-a1/2
mice.
Our finding that TNF-a–induced acceleration of neu-
trophil apoptosis was not augmented in A1-a2/2 is appar-
ently inconsistent with the previous finding that transfec-
tion of the A1 gene into an endothelial cell line resulted in
inhibition of TNF-a–induced apoptosis of these cells (19).
This apparent discrepancy may be reconciled as follows:
first, although the discoveries of TNF receptor-binding cy-
toplasmic proteins such as TNF receptor 1-associated death
domain protein (41) and TNF receptor–associated factor
(42, 43) have expanded our understanding of the mecha-
nisms of TNF-a–induced apoptosis, the picture is far from
clear. Various molecules such as IL-1b–converting en-
zyme–like protease (44), ceramide (45, 46), reactive oxy-
gen intermediates (47), and nicotinamide dinucleotide (48)
have been proposed as candidates for mediators of TNF-a–
induced apoptosis. On the other hand, nitric oxide (49)
and A20 zinc finger protein (50) are both thought to be in-
hibitors of this form of apoptosis. Apoptosis induction and
inhibition through mechanisms involving the above mole-
cules are dependent on cell type (44–50). Therefore, signal
transductions governing TNF-a–induced apoptosis may
differ in neutrophils and endothelial cells. Secondly, a dif-
ference in the manner of TNF-a–induced apoptosis of the
two cell types may explain the discrepancy in the results,
i.e., why addition of actinomycin D is required for TNF-a–
induced apoptosis of endothelial cells (19) while TNF-a
alone is sufficient to induce neutrophil apoptosis (1, 2). In
addition, our preliminary results suggesting that the GM-
CSF–induced inhibition of neutrophil apoptosis was not
abolished in A1-a2/2 mice (Hamasaki, A., unpublished re-
sults) themselves suggest that there exist systems of neutro-
phil apoptosis regulation other than those shown in this
manuscript.
The unexpected result that the number of PBN and
PEN was not significantly different in A1-a2/2, A1-a1/2,
and wild-type mice may be explained as follows: (a) various
systems other than A1, involved in the regulation of neu-
trophil apoptosis may compensate for this apoptosis in vivo;
(b) positive feedback regulation of PBN number may be in-
duced in A1-a2/2 mice through cytokines such as G-CSF;
Figure 5. Modulation of PBN and PEN apoptosis by TNF-a in A1-
a2/2, A1-a1/2, and wild-type mice. Aliquots (0.4 ml, 0.5 3 106/ml) of
PBN (a, c, and e) and PEN (b, d, and f) were incubated for a period of up
to 12 h in the presence or absence of recombinant human TNF-a (100
U/ml). The numbers of apoptotic neutrophils were determined by light
microscopic observation, as described in Materials and Methods. The re-
sults are expressed as means and SEs of five experiments. The unpaired t
test was used to identify significant differences (*P , 0.01) between the
groups in the presence and absence of TNF-a.1991 Hamasaki et al.
and (c) a less probable possibility is that preapoptotic change
in cell surface carbohydrates which induce phagocytosis by
macrophages (51) may not differ between A1-a2/2, A1-
a1/2, and wild-type mice and this may result in the same
grade of phagocytosis of preapoptotic neutrophils in these
strains of mice.
Studies are now in progress to more precisely elucidate
the mechanisms of A1 involvement in the inhibition of
neutrophil apoptosis and to examine whether A1 is also in-
volved in the inhibition of apoptosis of myeloid cells other
than neutrophils.
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